SASSI NIR (Chief Financial Officer) received a stock award from INDAPTUS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/29/2025ACC: 0001493152-25-029356
Officer· Chief Financial Officer
Since Jul 2021
+26.76K
Net shares
Net buyer
$54.3K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
26.76K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+26.76K
Price / share
$2.03
Trade value
$54.32K
% of position
New position
12/22/2025
0.00→26.76K
Total
Net shares
+26.76K
Net value
$54.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/22/2025 | A · Award | +26.76K | $2.03 | $54.32K | New position | 0.00 | 26.76K |
| Total | +26.76K | $54.32K | ||||||
Derivative Transactions0
No derivative transactions reported